Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrolidine SCHEMBL9110026 | 0.90 | CRBN (0.33) | MAP3K14CRBNGLANPC1HSD17B10 | |
| SCHEMBL20031168 | 0.82 | NPC1 (0.41) | MAP3K14CRBNGLANPC1KDM4E | |
| SCHEMBL19851229 | 0.82 | MAP3K14 (0.40) | MAP3K14CRBNGLANPC1BRD4 | |
| SCHEMBL31435687 | 0.81 | CRBN (0.40) | CRBN | |
| SCHEMBL20021318 | 0.80 | NPC1 (0.40) | MAP3K14CRBNGLANPC1ACE | |
| SCHEMBL6078384 | 0.79 | ALDH1A1 (0.41) | MAP3K14CRBNNPC1ACEKDM4E | |
| SCHEMBL6079243 | 0.79 | ALDH1A1 (0.41) | MAP3K14CRBNNPC1ACEKDM4E | |
| SCHEMBL22085274 | 0.79 | ALDH1A1 (0.41) | MAP3K14CRBNNPC1ACEKDM4E | |
| SCHEMBL27727578 | 0.79 | ALDH1A1 (0.41) | MAP3K14CRBNNPC1ACEKDM4E | |
| SCHEMBL6077962 | 0.79 | ALDH1A1 (0.41) | MAP3K14CRBNNPC1ACEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2431502-B1 | CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS | ROHM & HAAS ELECT MAT (US) | 2017-05-24 | — | — | EP | claimed |
| CN-102409373-B | Cyanide-free silver electroplating solutions | ROHM AND HAAS COMPANY ELECT MATERIALS | 2015-05-20 | — | — | CN | claimed |
| CN-102409372-B | Method of electroplating silver strike over nickel | ROHM & HAAS ELECT MAT | 2015-02-11 | — | — | CN | claimed |
| EP-2431501-B1 | Method of electroplating silver strike over nickel | ROHM & HAAS ELECT MAT (US) | 2013-11-20 | — | — | EP | claimed |
| CN-102409372-A | Method of electroplating silver strike over nickel | ROHM & HAAS ELECT MAT | 2012-04-11 | — | — | CN | claimed |
| US-20120067733-A1 | METHOD OF ELECTROPLATING SILVER STRIKE OVER NICKEL | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-03-22 | — | — | US | claimed |
| EP-2431501-A1 | Method of electroplating silver strike over nickel | Rohm and Haas Electronic Materials LLC (US) | 2012-03-21 | — | — | EP | claimed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-20220008549-A1 | NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2022-01-13 | — | — | US | disclosed |
| US-20210236410-A1 | HAIR COSMETIC COMPRISING BLOCK COPOLYMER | SHISEIDO COMPANY, LTD. (JP) | 2021-08-05 | — | — | US | disclosed |
| US-20210214514-A1 | POROUS BODY, AND METHOD FOR PRODUCING POROUS BODY | EMAUS KYOTO, INC. (JP) | 2021-07-15 | — | — | US | disclosed |
| CN-112203635-A | Inorganic particle dispersion liquid for cosmetic containing block copolymer | 株式会社资生堂 | 2021-01-08 | — | — | CN | disclosed |
| CN-112203636-A | Hair cosmetic comprising block copolymer | 株式会社资生堂 | 2021-01-08 | — | — | CN | disclosed |
| CN-1741993-A | Process for producing cyclic amines | NEW JAPAN CHEM CO LTD (JP) | 2006-03-01 | — | — | CN | disclosed |
| US-6210816-B1 | Translucent xerographic recording substrates | XEROX CORPORATION | 2001-04-03 | — | — | US | disclosed |
| US-5622137-A | FOR USE IN TESTING COOKED FOODS | TRANS WORLD SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
| US-5242892-A | With 5-aminolevulinic acid | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1993-09-07 | — | — | US | disclosed |
| US-4246077-A | SILVER COMPLEX OF 3-PYRROLINE-2,5-DIONE OR PYRROLIDINE-2,5-DIONE | TECHNIC, INC. (US) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220008549-A1 | NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF | STING1, CGAS, TLR9 | MAP3K14 1509/4885CRBN 914/4885GLA 3244/4885 |
| US-20210236410-A1 | HAIR COSMETIC COMPRISING BLOCK COPOLYMER | DNMT1, H1-0, H1-5 | MAP3K14 4637/4885CRBN 2937/4885GLA 1312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.